Anemia in older adults stems from three broad categories of roughly equal size: nutritional deficiencies (especially iron, vitamin B12, and folate), chronic inflammation paired with kidney disease, and a frustrating “unexplained” group where no single obvious cause emerges.1PubMed Central. Anemia in the elderly: clinical implications and new therapeutic concepts Each category accounts for about a third of cases, though in practice these causes overlap and feed into one another in ways that make anemia in older people far harder to untangle than anemia in a younger adult.
Nutritional Deficiencies Are the Most Treatable Third
Iron deficiency is the single most common nutritional driver of anemia at any age, but in older adults it rarely comes from a poor diet alone. The usual culprit is slow, chronic blood loss from the gastrointestinal tract. Ulcers, polyps, and colorectal cancers can bleed so gradually that you never see blood in the stool, yet over weeks or months the iron stores quietly drain. In one study of elderly patients with iron deficiency, about half had a significant lesion in the upper GI tract and roughly a third had one in the lower tract. Colorectal cancer was the most common finding in the colon, and more than half of those cancer patients had no symptoms at all.2The American Journal of Medicine. Diagnostic value of upper and lower gastrointestinal evaluation in elderly patients with iron deficiency That finding is worth pausing on: iron-deficiency anemia in an older person is not just a nutritional nuisance. It can be the first sign of a hidden cancer, which is why doctors push for endoscopic workup even when the anemia looks mild.
Vitamin B12 deficiency is another common contributor, and its causes are different from what most people assume. Rather than simply not eating enough B12, older adults tend to lose the ability to absorb it. Autoimmune gastritis, which damages the stomach lining, and long-term use of acid-suppressing medications like proton pump inhibitors both interfere with B12 uptake.3PubMed Central. Cobalamin Deficiency in the Elderly Folate deficiency, the third nutritional cause, is less common today in countries that fortify grain products, but it still turns up in people with very restricted diets, heavy alcohol use, or certain medications that block folate metabolism.
Protein and calorie malnutrition also play a role that tends to be underappreciated. When an older person is eating too little overall, the body’s inflammatory signaling ramps up, which in turn raises levels of hepcidin, a hormone that locks iron inside cells and keeps it out of the bloodstream. So even malnutrition that looks like a simple calorie deficit can trigger the same iron-trapping mechanism seen in chronic inflammatory diseases.4PubMed. Role of nutrition on anemia in elderly Obesity can do something similar: excess body fat generates chronic low-grade inflammation, which again drives up hepcidin and restricts iron availability.
Chronic Inflammation and Kidney Disease
The second third of elderly anemia cases arise from conditions that suppress red blood cell production through inflammation. This is often called “anemia of chronic disease,” and it shows up alongside infections, autoimmune disorders, cancer, and chronic kidney disease.5PubMed Central. Anemia of Chronic Disease Revisited: Hepcidin Dysregulation, Erythropoietic Failure, and Emerging Roles of SGLT2 Inhibition The mechanism centers on iron sequestration: inflammatory signals cause the body to hoard iron in storage cells rather than releasing it for red blood cell production. Even if total iron stores look normal on a blood test, the iron is effectively unavailable. Studies have shown that patients with anemia of chronic disease have significantly elevated levels of interleukin-6 and hepcidin compared to healthy controls, confirming that inflammatory signaling is driving the iron lockdown.6PubMed Central. Effect of Interleukin and Hepcidin in Anemia of Chronic Diseases
Chronic kidney disease adds another layer. Healthy kidneys produce erythropoietin (EPO), the hormone that tells bone marrow to make red blood cells. As kidney function declines with age, EPO production drops. Research from the InCHIANTI study found that older adults with severely reduced kidney filtration had significantly lower EPO levels compared to those with normal function.7Archives of Internal Medicine. Renal Function, Erythropoietin, and Anemia of Older Persons: The InCHIANTI Study Mild kidney decline may not be enough on its own to cause frank anemia, but it chips away at the body’s ability to compensate when other factors pile on. With very advanced age, or when conditions like diabetes or long-standing high blood pressure have damaged the kidneys further, this compensatory mechanism can fail entirely.8PubMed. Serum erythropoietin and aging: a longitudinal analysis
Unexplained Anemia and the Testosterone Connection
In roughly one out of three older adults with anemia, standard workups come back without a clear explanation. This “unexplained anemia of the elderly” is not really a single disease. It is a catch-all for cases where mild kidney insufficiency, low-grade inflammation, testosterone deficiency, and age-related decline in bone marrow stem cell function each contribute a little, but none crosses the threshold that would flag it as the obvious cause on its own.9PubMed Central. Unexplained anemia in the elderly
Testosterone’s role is one of the more interesting pieces of this puzzle. As men and women age, testosterone levels decline, and lower testosterone is linked to lower hemoglobin. A longitudinal analysis found that older adults with low testosterone were more likely to already be anemic and more likely to develop anemia over the next three years, even after accounting for iron, B12, and folate levels.10JAMA Internal Medicine. Low Testosterone Levels and the Risk of Anemia in Older Men and Women In a controlled trial, testosterone treatment corrected anemia in a striking proportion of men: among those with unexplained anemia, about 54% who received testosterone saw their hemoglobin rise by at least 1 g/dL, compared to only 15% on placebo. By the end of the trial, nearly 60% of the testosterone group was no longer anemic, versus about 22% of those on placebo.11PubMed Central. Association of Testosterone Levels With Anemia in Older Men: A Controlled Clinical Trial Testosterone therapy carries its own risks, so it is not a blanket solution, but the finding underlines how hormonal decline is a genuine contributor to anemia that standard blood panels often overlook.
Medications as a Hidden Contributor
Older adults tend to take more medications, and several common drug classes can promote or worsen anemia. NSAIDs are among the worst offenders. They can cause inflammation throughout the small intestine, leading to chronic blood loss that is difficult to detect on standard tests. Large intestinal ulcers, bleeding, and even perforation occasionally result from long-term NSAID use.12Current Clinical Pharmacology. Drug-Induced Anemia and Other Red Cell Disorders: A Guide in the Age of Polypharmacy The irony is that many older adults take NSAIDs for arthritis or chronic pain, conditions that themselves generate the inflammatory signals contributing to anemia of chronic disease. So the drug treats the pain while potentially making the anemia worse through two separate pathways.
Beyond NSAIDs, proton pump inhibitors (the acid-suppressing drugs mentioned earlier) reduce absorption of both iron and B12 over time. Certain chemotherapy agents, immunosuppressants, and antivirals can directly suppress the bone marrow. When someone is on five, eight, or twelve medications simultaneously, teasing apart which one might be contributing to falling hemoglobin becomes a real clinical challenge.
Bone Marrow Disorders That Mimic “Normal” Aging
Myelodysplastic syndromes, or MDS, are a group of bone marrow cancers that overwhelmingly affect older adults. Among people over 80, the incidence exceeds 50 new cases per 100,000 per year.13PubMed Central. Myelodysplastic syndromes: diagnosis, prognosis, and treatment MDS often presents as nothing more than persistent anemia, sometimes with low white blood cells or platelets as well. Because the anemia looks bland on initial tests, MDS can be misdiagnosed as unexplained anemia for months or years before a bone marrow biopsy reveals the underlying problem.
Separately, researchers have discovered that many older adults carry clonal mutations in their blood cells, a phenomenon that increases with age. Specific mutations in genes like DNMT3A, TET2, and ASXL1 are common. However, single mutations of this type have not been correlated with the presence of unexplained anemia in older adults, suggesting that clonal blood changes alone do not explain the anemia puzzle.14PubMed. Anemia in older adults as a geriatric syndrome: A review The relationship between these age-related mutations and blood counts is still being worked out.
Why Diagnosis Is So Tricky in Older Adults
Part of the difficulty starts with how anemia is defined. The widely used WHO thresholds were derived from younger populations, and whether they are appropriate for elderly individuals is still debated. Hemoglobin naturally drifts downward with age, so a level that would be clearly abnormal in a 30-year-old might sit in a gray zone for an 80-year-old.1PubMed Central. Anemia in the elderly: clinical implications and new therapeutic concepts Using thresholds that are too strict could label healthy older people as anemic; using thresholds that are too lenient could miss real cases that deserve treatment.
Even once anemia is confirmed, figuring out why it is there gets complicated. The classic distinction between iron deficiency anemia and anemia of chronic disease relies heavily on ferritin, but ferritin rises during inflammation, masking underlying iron deficiency. Newer markers like soluble transferrin receptor and the ratio of soluble transferrin receptor to log-ferritin can help. In one multicenter evaluation, combining ferritin with these newer markers more than doubled the detection rate of true iron deficiency, from about 41% with ferritin alone to 92%.15PubMed. Improved differential diagnosis of anemia of chronic disease and iron deficiency anemia: a prospective multicenter evaluation of soluble transferrin receptor and the sTfR/log ferritin index These tests are not always ordered routinely, though, which means some cases of treatable iron deficiency hiding behind inflammatory markers get missed.
Consequences That Go Beyond Feeling Tired
Anemia in older adults is not just a lab number. It tracks closely with outcomes that matter for daily life. In community-dwelling older adults, anemia has been linked to greater fatigue, weaker grip strength, more disabilities, and more depressive symptoms.16PubMed Central. Diminished quality of life and physical function in community-dwelling elderly with anemia Population data consistently show that anemia correlates with functional decline, disability, and increased mortality.17PubMed Central. Anemia in frailty
The mortality risk is compounded when anemia overlaps with frailty. In one study, frail older adults without anemia already had roughly triple the mortality risk of robust individuals, but frail adults who also had anemia had about four and a half times the risk.18PubMed Central. La anemia aumenta el riesgo de mortalidad debido a fragilidad y discapacidad en mayores: Estudio FRADEA Anemia and frailty together seem to amplify each other’s harm.19PubMed. Mortality from all-cause and cause-specific in the elderly: Joint implications of anemia and frailty
Perhaps most surprisingly, anemia is associated with a higher risk of dementia. One large study followed older adults over time and found that those who were anemic at the start had about a 64% higher risk of developing dementia compared to those without anemia, even after adjusting for other health factors.20PubMed Central. Anemia and risk of dementia in older adults: Findings from the Health ABC study Another large study found a U-shaped pattern: both low and high hemoglobin levels were tied to greater dementia risk, with anemia specifically associated with about a 34% increased risk overall and a 41% increase for Alzheimer’s disease.21PubMed Central. Hemoglobin and anemia in relation to dementia risk and accompanying changes on brain MRI The mechanism is not fully understood. Chronic oxygen deprivation to brain tissue is one plausible explanation, but the association could also reflect shared underlying causes like inflammation and vascular disease.
The Cardio-Renal Anemia Cycle
One pattern that clinicians see frequently in older patients is the vicious triangle of heart failure, kidney disease, and anemia. Each condition worsens the other two. Heart failure reduces blood flow to the kidneys, worsening kidney function. Damaged kidneys produce less EPO, deepening anemia. Anemia forces the heart to work harder to deliver oxygen, worsening heart failure.22PubMed Central. Cardio-renal anemia syndrome Once this cycle is established, treating just one corner of the triangle without addressing the others often fails. It is a major reason why anemia in older adults with heart or kidney problems tends to be stubborn and recurrent.
When Oral Iron Is Not Enough
For the nutritional subset of cases, treatment sounds straightforward: replace whatever is missing. But in practice, oral iron supplements are poorly tolerated by many older adults. Nausea, constipation, and stomach pain lead people to skip doses or stop entirely. More importantly, in the setting of chronic inflammation, oral iron may simply not be absorbed well because of the hepcidin-mediated iron blockade described earlier.
Intravenous iron has become an increasingly important tool. It bypasses the gut entirely, restores iron stores effectively, and improves hemoglobin, functional status, and quality of life while reducing the need for blood transfusions. It is especially useful in older adults with chronic kidney disease, heart failure, or gastrointestinal conditions that make oral iron impractical. Serious adverse events from IV iron are rare, though infusion reactions, temporary drops in blood pressure, and low phosphate levels can occur.23PubMed. Intravenous Iron Use in Older Adults
For anemia driven by kidney disease, synthetic EPO injections can stimulate red blood cell production directly, though they come with their own risks including blood clots and elevated blood pressure. B12 deficiency usually responds well to injections or high-dose oral supplements. The trickiest cases are those where the anemia has no single treatable cause, or where multiple mild contributors stack on top of each other. In those situations, managing the underlying conditions, adjusting medications, optimizing nutrition, and sometimes accepting a modestly lower hemoglobin as a trade-off against the risks of aggressive treatment becomes the realistic approach.